Osel, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer (NCT06399419) | Osel, Inc. | 2024-06-19 |
Track Osel, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.